oxybutynin has been researched along with Hyperlipemia in 2 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Excerpt | Relevance | Reference |
---|---|---|
"The goal of the present investigation was to improve ATV bioavailability and overcome complications attendant with peroral administration by developing a new nanovesicular system encapsulating ATV for its delivery via the transdermal route." | 1.46 | Transdermal delivery of atorvastatin calcium from novel nanovesicular systems using polyethylene glycol fatty acid esters: Ameliorated effect without liver toxicity in poloxamer 407-induced hyperlipidemic rats. ( Aboud, HM; Ali, AA; Hassan, AH; Johnston, TP; Mahmoud, MO, 2017) |
" Thus, the patch may serve as an alternative therapy to oral dosage form of simvastatin with outmost patient compliance." | 1.43 | Application of Response Surface Methodology for Design and Optimization of Reservoir-type Transdermal Patch of Simvastatin. ( Parhi, R; Patnaik, S; Suresh, P, 2016) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mahmoud, MO | 1 |
Aboud, HM | 1 |
Hassan, AH | 1 |
Ali, AA | 1 |
Johnston, TP | 1 |
Parhi, R | 1 |
Suresh, P | 1 |
Patnaik, S | 1 |
2 other studies available for oxybutynin and Hyperlipemia
Article | Year |
---|---|
Transdermal delivery of atorvastatin calcium from novel nanovesicular systems using polyethylene glycol fatty acid esters: Ameliorated effect without liver toxicity in poloxamer 407-induced hyperlipidemic rats.
Topics: Administration, Cutaneous; Animals; Atorvastatin; Biological Availability; Chemistry, Pharmaceutical | 2017 |
Application of Response Surface Methodology for Design and Optimization of Reservoir-type Transdermal Patch of Simvastatin.
Topics: Administration, Cutaneous; Animals; Biomarkers; Cyclohexenes; Disease Models, Animal; Drug Compoundi | 2016 |